Compounds of Formula (I), in which A, B, R1, R1a, R2, R3, R4, R5, R6, and R7 have the meanings given in the specification, are receptor tyrosine inhibitors useful in the treatment of immune cell-associated diseases and disorders, such as inflammatory and autoimmune diseases.
公式(I)的化合物,其中A、B、R1、R1a、R2、R3、R4、R5、R6和R7的含义如规范中所述,是在治疗免疫
细胞相关疾病和紊乱方面有用的受体
酪氨酸激酶
抑制剂,例如炎症性和自身免疫疾病。